368 related articles for article (PubMed ID: 19255410)
1. APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old.
Berlau DJ; Corrada MM; Head E; Kawas CH
Neurology; 2009 Mar; 72(9):829-34. PubMed ID: 19255410
[TBL] [Abstract][Full Text] [Related]
2. Association of
Qian J; Betensky RA; Hyman BT; Serrano-Pozo A
Neurology; 2021 May; 96(19):e2414-e2428. PubMed ID: 33771840
[TBL] [Abstract][Full Text] [Related]
3. Dissociation of neuropathologic findings and cognition: case report of an apolipoprotein E epsilon2/epsilon2 genotype.
Berlau DJ; Kahle-Wrobleski K; Head E; Goodus M; Kim R; Kawas C
Arch Neurol; 2007 Aug; 64(8):1193-6. PubMed ID: 17698712
[TBL] [Abstract][Full Text] [Related]
4. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
[TBL] [Abstract][Full Text] [Related]
5. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
[TBL] [Abstract][Full Text] [Related]
6. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
7. Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status.
Reas ET; Triebswetter C; Banks SJ; McEvoy LK
Alzheimers Res Ther; 2024 Jan; 16(1):7. PubMed ID: 38212861
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
[TBL] [Abstract][Full Text] [Related]
9. APOE2: protective mechanism and therapeutic implications for Alzheimer's disease.
Li Z; Shue F; Zhao N; Shinohara M; Bu G
Mol Neurodegener; 2020 Nov; 15(1):63. PubMed ID: 33148290
[TBL] [Abstract][Full Text] [Related]
10. Neocortical β-amyloid area is associated with dementia and APOE in the oldest-old.
Berlau DJ; Corrada MM; Robinson JL; Geser F; Arnold SE; Lee VM; Kawas CH; Trojanowski JQ
Alzheimers Dement; 2013 Nov; 9(6):699-705. PubMed ID: 23474043
[TBL] [Abstract][Full Text] [Related]
11. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.
Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G
Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773
[TBL] [Abstract][Full Text] [Related]
12. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
[TBL] [Abstract][Full Text] [Related]
13. Human ApoE ɛ2 Promotes Regulatory Mechanisms of Bioenergetic and Synaptic Function in Female Brain: A Focus on V-type H+-ATPase.
Woody SK; Zhou H; Ibrahimi S; Dong Y; Zhao L
J Alzheimers Dis; 2016 Jun; 53(3):1015-31. PubMed ID: 27340853
[TBL] [Abstract][Full Text] [Related]
14. APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults.
Lamar M; Yu L; Rubin LH; James BD; Barnes LL; Farfel JM; Gaiteri C; Buchman AS; Bennett DA; Schneider JA
Alzheimers Dement; 2019 Feb; 15(2):258-266. PubMed ID: 30321502
[TBL] [Abstract][Full Text] [Related]
15. AD and non-AD mediators of the pathway between the APOE genotype and cognition.
Nichols E; Brickman AM; Casaletto KB; Dams-O'Connor K; George KM; Kumar RG; Palta P; Rabin JS; Satizabal CL; Schneider J; Pa J; La Joie R
Alzheimers Dement; 2023 Jun; 19(6):2508-2519. PubMed ID: 36516004
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
Baum L; Chen L; Ng HK; Pang CP
Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
[TBL] [Abstract][Full Text] [Related]
17. APOE ε4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death.
Yu L; Boyle P; Schneider JA; Segawa E; Wilson RS; Leurgans S; Bennett DA
Psychol Aging; 2013 Dec; 28(4):1015-23. PubMed ID: 23647000
[TBL] [Abstract][Full Text] [Related]
18. APOEε2 is associated with milder clinical and pathological Alzheimer disease.
Serrano-Pozo A; Qian J; Monsell SE; Betensky RA; Hyman BT
Ann Neurol; 2015 Jun; 77(6):917-29. PubMed ID: 25623662
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort.
Berge G; Sando SB; Rongve A; Aarsland D; White LR
J Neurol Neurosurg Psychiatry; 2014 Nov; 85(11):1227-31. PubMed ID: 24639435
[TBL] [Abstract][Full Text] [Related]
20. Human Apolipoprotein E Genotype Differentially Affects Olfactory Behavior and Sensory Physiology in Mice.
East BS; Fleming G; Peng K; Olofsson JK; Levy E; Mathews PM; Wilson DA
Neuroscience; 2018 Jun; 380():103-110. PubMed ID: 29678753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
